Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Tonix Pharmaceuticals Hol...

    NASDAQ: TNXP · Real-Time Price · USD
    40.62
    2.21 (5.75%)
    At close: Jun 06, 2025, 3:59 PM
    40.25
    -0.91%
    After-hours: Jun 06, 2025, 05:49 PM EDT

    Tonix Pharmaceuticals Statistics

    Share Statistics

    Tonix Pharmaceuticals has 7.32M shares outstanding. The number of shares has increased by 2964.8% in one year.

    Shares Outstanding

    n/a
    		 7.32M

    Shares Change (YoY)

    n/a
    		 2964.8%

    Shares Change (QoQ)

    n/a
    		 14.77%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 3,970

    FTD / Avg. Volume

    n/a
    		 0.24%

    Short Selling Information

    The latest short interest is 908.35K, so 12.4% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 908.35K

    Short % of Shares Out

    n/a
    		 12.4%

    Short % of Float

    n/a
    		 12.4%

    Short Ratio (days to cover)

    n/a
    		 1.43

    Valuation Ratios

    The PE ratio is -0.57 and the forward PE ratio is -6.39. Tonix Pharmaceuticals's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.57

    Forward PE

    n/a
    		 -6.39

    PS Ratio

    n/a
    		 7.4

    Forward PS

    n/a
    		 0.4

    PB Ratio

    n/a
    		 0.53

    P/FCF Ratio

    n/a
    		 -1.22

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Tonix Pharmaceuticals.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.5, with a Debt / Equity ratio of 0.06.

    Current Ratio

    n/a
    		 6.5

    Quick Ratio

    n/a
    		 6.04

    Debt / Equity

    n/a
    		 0.06

    Debt / EBITDA

    n/a
    		 -0.11

    Debt / FCF

    n/a
    		 -0.13

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $124,617.28

    Profits Per Employee

    n/a
    		 $-1,605,382.72

    Employee Count

    n/a
    		 81

    Asset Turnover

    n/a
    		 0.06

    Inventory Turnover

    n/a
    		 0.92

    Taxes

    Income Tax

    n/a
    		 -1.17M

    Effective Tax Rate

    n/a
    		 0.9%

    Stock Price Statistics

    The stock price has increased by -89% in the last 52 weeks. The beta is 2.1, so Tonix Pharmaceuticals's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.1

    52-Week Price Change

    n/a
    		 -89%

    50-Day Moving Average

    n/a
    		 22.97

    200-Day Moving Average

    n/a
    		 21.19

    Relative Strength Index (RSI)

    n/a
    		 67.34

    Average Volume (20 Days)

    n/a
    		 1,650,757

    Income Statement

    In the last 12 months, Tonix Pharmaceuticals had revenue of 10.09M and earned -130.04M in profits. Earnings per share was -3504.

    Revenue

    n/a
    		 10.09M

    Gross Profit

    n/a
    		 2.33M

    Operating Income

    n/a
    		 -77.74M

    Net Income

    n/a
    		 -130.04M

    EBITDA

    n/a
    		 -74.94M

    EBIT

    n/a
    		 -75.7M

    Earnings Per Share (EPS)

    n/a
    		 -3504
    Full Income Statement

    Balance Sheet

    The company has 98.78M in cash and 8.12M in debt, giving a net cash position of 90.66M.

    Cash & Cash Equivalents

    n/a
    		 98.78M

    Total Debt

    n/a
    		 8.12M

    Net Cash

    n/a
    		 90.66M

    Retained Earnings

    n/a
    		 -730.69M

    Total Assets

    n/a
    		 192.87M

    Working Capital

    n/a
    		 137.43M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -60.92M and capital expenditures -120K, giving a free cash flow of -61.05M.

    Operating Cash Flow

    n/a
    		 -60.92M

    Capital Expenditures

    n/a
    		 -120K

    Free Cash Flow

    n/a
    		 -61.05M

    FCF Per Share

    n/a
    		 -26.97
    Full Cash Flow Statement

    Margins

    Gross margin is 23.07%, with operating and profit margins of -770.2% and -1288.25%.

    Gross Margin

    n/a
    		 23.07%

    Operating Margin

    n/a
    		 -770.2%

    Pretax Margin

    n/a
    		 -1288.25%

    Profit Margin

    n/a
    		 -1288.25%

    EBITDA Margin

    n/a
    		 -742.39%

    EBIT Margin

    n/a
    		 -770.2%

    FCF Margin

    n/a
    		 -604.77%

    Dividends & Yields

    TNXP does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TNXP is $585, which is 1427.4% higher than the current price. The consensus rating is "Strong Buy".

    Price Target

    n/a
    		 $585

    Price Target Difference

    n/a
    		 1427.4%

    Analyst Consensus

    n/a
    		 Strong Buy

    Analyst Count

    n/a
    		 2
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Feb 5, 2025. It was a backward split with a ratio of 1:100.

    Last Split Date

    n/a
    		 Feb 5, 2025

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:100

    Scores

    Altman Z-Score

    n/a
    		 9.04

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist